Clinical Trial

Patient Preference Study: Standard of Care Versus Once-daily Trientine Tetrahydrochloride

Completed Phase 2
View on ClinicalTrials.gov →
Summary
Decentralized study to assess patient reported treatment satisfaction comparing their current standard-of-care Wilson's Disease (WD) treatment with a new once-daily Trientine (TETA) 4HCl formulation.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-05-29; most recent amendment 2026-03-31.
Status change: Active, Not Recruiting → Completed 2026-01-08
Status change: Recruiting → Active, Not Recruiting 2025-11-20
Status change: Not Yet Recruiting → Recruiting 2025-07-28
Trial Details
NCT Number NCT07010575
Lead Sponsor Orphalan
Conditions Wilson's Disease
Enrollment 10 participants
Start Date 2025-07-15
Primary Completion 2025-12-18 (estimated)
Study Completion 2025-12-18 (estimated)
Updated on ClinicalTrials.gov 2026-04-06